BNGO:NSD-Bionano Genomics Inc (USD)

COMMON STOCK | Diagnostics & Research | NSD

Last Closing Price

USD 1.57

Change

-0.05 (-3.09)%

Market Cap

USD 0.47B

Volume

5.18M

Avg Analyst Target

USD 10.50 (+568.79%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


Bionano Genomics Inc (BNGO) Stock Analysis:
Based on the Bionano Genomics Inc stock forecasts from 2 analysts, the average analyst target price for Bionano Genomics Inc is USD 10.50 over the next 12 months. Bionano Genomics Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Bionano Genomics Inc is Very Bearish, which is based on 0 positive signals and 3 negative signals. At the last closing, Bionano Genomics Inc’s stock price was USD 1.57. Bionano Genomics Inc’s stock price has changed by +14.60% over the past week, -24.15% over the past month and -70.93% over the last year.

About

Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molec ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-05-16 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
IDXX IDEXX Laboratories Inc

-1.98 (-0.55%)

USD30.43B 42.11 28.03
ICLR ICON Public Limited Company

-0.48 (-0.23%)

USD17.15B 94.41 27.29
PRAH PRA Health Sciences, Inc

N/A

USD10.70B 50.52 25.79
EXAS Exact Sciences Corporation

-1.74 (-3.33%)

USD9.20B N/A N/A
SYNH Syneos Health Inc

-0.15 (-0.21%)

USD7.19B 30.32 15.99
MEDP Medpace Holdings Inc

+0.47 (+0.34%)

USD4.48B 24.90 19.21
LNTH Lantheus Holdings Inc

+2.89 (+4.52%)

USD4.09B 2,335.00 197.83
GH Guardant Health Inc

-0.82 (-2.28%)

USD3.66B N/A N/A
NEOG Neogen Corporation

-0.53 (-2.00%)

USD2.85B 57.94 29.29
NTRA Natera Inc

-0.28 (-0.82%)

USD2.78B N/A N/A

ETFs Containing BNGO

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Diagnostics & Research)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -47.49% 50% F 26% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -47.49% 50% F 26% F
Trailing 12 Months  
Capital Gain -71.96% 40% F 17% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -71.96% 40% F 17% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 250.31% 96% A 98% A+
Dividend Return N/A N/A N/A N/A N/A
Total Return 250.31% 96% A 98% A+
Risk Return Profile  
Volatility (Standard Deviation) 543.05% 9% F 3% F
Risk Adjusted Return 46.09% 63% D 74% C
Market Capitalization 0.47B 57% F 58% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Diagnostics & Research)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 1.31 57% F 59% F
Price / Cash Flow Ratio -6.52 80% B- 73% C
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity -38.92% 48% F 28% F
Return on Invested Capital -42.63% 39% F 23% F
Return on Assets -21.60% 38% F 19% F
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio 6.67 32% F 21% F
Short Percent 15.61% 5% F 11% F
Beta 1.94 12% F 12% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector